Fulgent Genetics (FLGT) Short term Debt (2020 - 2023)

Fulgent Genetics has disclosed Short term Debt across 4 years of filings, most recently posting $15.0 million for Q1 2023.

• In Q1 2023, Short term Debt changed 0.01% year-over-year to $15.0 million; the TTM figure through Mar 2023 stood at $15.0 million (changed 0.01% YoY), while the FY2022 annual figure was $15.0 million, down 0.91% from the prior year.
• Short term Debt came in at $15.0 million for Q1 2023 at Fulgent Genetics, roughly flat from $15.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $15.1 million in Q4 2021 to a low of $15.0 million in Q4 2022.
• Average Short term Debt over 4 years is $15.0 million, with a median of $15.0 million recorded in 2020.
• Year-over-year, Short term Debt climbed 0.79% in 2021 and retreated 0.91% in 2022.
• Over 4 years, Short term Debt stood at $15.0 million in 2020, then grew by 0.79% to $15.1 million in 2021, then slipped by 0.91% to $15.0 million in 2022, then changed by 0.0% to $15.0 million in 2023.
• Per Business Quant data, the three most recent Short term Debt figures were $15.0 million in Q1 2023, $15.0 million in Q4 2022, and $15.0 million in Q3 2022.